Work

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

Year: 2008

Type: article

Source: Biomarkers

DOI: 10.1080/13547500802445199

Authors: Emma L. Akuffo, John B. Davis, Steven M. Fox, Israel S. Gloger, David Hosford, Emma E. Kinsey, Neil A. Jones, Christina M. Nock, Allen D. Roses, Ann M. Saunders, J. Mark Skehel, Marjorie A. Smith, Paul Cutler

Institutions: GlaxoSmithKline (United Kingdom), Duke Medical Center, GlaxoSmithKline (United States), Cancer Research UK

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1966010449

FWCI: 3.422

Cites: 21

Cited by: 53

Related to: 10